Click for best price
AntiVEGF Drug Market Size, Share 2024
The global Anti-VEGF Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Avastin Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anti-VEGF Drug include F. Hoffmann-La Roche Ltd, Amgen Inc, Pfizer, Inc, Xbrane Biopharma AB, Allergan, Bayer AG, Regeneron Pharmaceuticals Inc. and Viatris Inc, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-VEGF Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-VEGF Drug. This report contains market size and forecasts of Anti-VEGF Drug in global, including the following market information:
Global Anti-VEGF Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Anti-VEGF Drug Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Anti-VEGF Drug companies in 2023 (%)
We surveyed the Anti-VEGF Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-VEGF Drug Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Anti-VEGF Drug Market Segment Percentages, by Type, 2023 (%)
Avastin
Lucentis
Eylea
Global Anti-VEGF Drug Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Anti-VEGF Drug Market Segment Percentages, by Application, 2023 (%)
Age-related Macular Degeneration
Macular Edema Following Retinal Vein Occlusion
Diabetic Macular Edema
Diabetic Retinopathy
Global Anti-VEGF Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Anti-VEGF Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-VEGF Drug revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Anti-VEGF Drug revenues share in global market, 2023 (%)
Key companies Anti-VEGF Drug sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Anti-VEGF Drug sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche Ltd
Amgen Inc
Pfizer, Inc
Xbrane Biopharma AB
Allergan
Bayer AG
Regeneron Pharmaceuticals Inc.
Viatris Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-VEGF Drug, market overview.
Chapter 2: Global Anti-VEGF Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-VEGF Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-VEGF Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-VEGF Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-VEGF Drug Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
76 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-VEGF Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-VEGF Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-VEGF Drug Overall Market Size
2.1 Global Anti-VEGF Drug Market Size: 2023 VS 2030
2.2 Global Anti-VEGF Drug Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Anti-VEGF Drug Sales: 2019-2030
3 Company Landscape
3.1 Top Anti-VEGF Drug Players in Global Market
3.2 Top Global Anti-VEGF Drug Companies Ranked by Revenue
3.3 Global Anti-VEGF Drug Revenue by Companies
3.4 Global Anti-VEGF Drug Sales by Companies
3.5 Global Anti-VEGF Drug Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Anti-VEGF Drug Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Anti-VEGF Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-VEGF Drug Players in Global Market
3.8.1 List of Global Tier 1 Anti-VEGF Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-VEGF Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-VEGF Drug Market Size Markets, 2023 & 2030
4.1.2 Avastin
4.1.3 Lucentis
4.1.4 Eylea
4.2 By Type - Global Anti-VEGF Drug Revenue & Forecasts
4.2.1 By Type - Global Anti-VEGF Drug Revenue, 2019-2024
4.2.2 By Type - Global Anti-VEGF Drug Revenue, 2025-2030
4.2.3 By Type - Global Anti-VEGF Drug Revenue Market Share, 2019-2030
4.3 By Type - Global Anti-VEGF Drug Sales & Forecasts
4.3.1 By Type - Global Anti-VEGF Drug Sales, 2019-2024
4.3.2 By Type - Global Anti-VEGF Drug Sales, 2025-2030
4.3.3 By Type - Global Anti-VEGF Drug Sales Market Share, 2019-2030
4.4 By Type - Global Anti-VEGF Drug Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-VEGF Drug Market Size, 2023 & 2030
5.1.2 Age-related Macular Degeneration
5.1.3 Macular Edema Following Retinal Vein Occlusion
5.1.4 Diabetic Macular Edema
5.1.5 Diabetic Retinopathy
5.2 By Application - Global Anti-VEGF Drug Revenue & Forecasts
5.2.1 By Application - Global Anti-VEGF Drug Revenue, 2019-2024
5.2.2 By Application - Global Anti-VEGF Drug Revenue, 2025-2030
5.2.3 By Application - Global Anti-VEGF Drug Revenue Market Share, 2019-2030
5.3 By Application - Global Anti-VEGF Drug Sales & Forecasts
5.3.1 By Application - Global Anti-VEGF Drug Sales, 2019-2024
5.3.2 By Application - Global Anti-VEGF Drug Sales, 2025-2030
5.3.3 By Application - Global Anti-VEGF Drug Sales Market Share, 2019-2030
5.4 By Application - Global Anti-VEGF Drug Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Anti-VEGF Drug Market Size, 2023 & 2030
6.2 By Region - Global Anti-VEGF Drug Revenue & Forecasts
6.2.1 By Region - Global Anti-VEGF Drug Revenue, 2019-2024
6.2.2 By Region - Global Anti-VEGF Drug Revenue, 2025-2030
6.2.3 By Region - Global Anti-VEGF Drug Revenue Market Share, 2019-2030
6.3 By Region - Global Anti-VEGF Drug Sales & Forecasts
6.3.1 By Region - Global Anti-VEGF Drug Sales, 2019-2024
6.3.2 By Region - Global Anti-VEGF Drug Sales, 2025-2030
6.3.3 By Region - Global Anti-VEGF Drug Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Anti-VEGF Drug Revenue, 2019-2030
6.4.2 By Country - North America Anti-VEGF Drug Sales, 2019-2030
6.4.3 US Anti-VEGF Drug Market Size, 2019-2030
6.4.4 Canada Anti-VEGF Drug Market Size, 2019-2030
6.4.5 Mexico Anti-VEGF Drug Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Anti-VEGF Drug Revenue, 2019-2030
6.5.2 By Country - Europe Anti-VEGF Drug Sales, 2019-2030
6.5.3 Germany Anti-VEGF Drug Market Size, 2019-2030
6.5.4 France Anti-VEGF Drug Market Size, 2019-2030
6.5.5 U.K. Anti-VEGF Drug Market Size, 2019-2030
6.5.6 Italy Anti-VEGF Drug Market Size, 2019-2030
6.5.7 Russia Anti-VEGF Drug Market Size, 2019-2030
6.5.8 Nordic Countries Anti-VEGF Drug Market Size, 2019-2030
6.5.9 Benelux Anti-VEGF Drug Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Anti-VEGF Drug Revenue, 2019-2030
6.6.2 By Region - Asia Anti-VEGF Drug Sales, 2019-2030
6.6.3 China Anti-VEGF Drug Market Size, 2019-2030
6.6.4 Japan Anti-VEGF Drug Market Size, 2019-2030
6.6.5 South Korea Anti-VEGF Drug Market Size, 2019-2030
6.6.6 Southeast Asia Anti-VEGF Drug Market Size, 2019-2030
6.6.7 India Anti-VEGF Drug Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Anti-VEGF Drug Revenue, 2019-2030
6.7.2 By Country - South America Anti-VEGF Drug Sales, 2019-2030
6.7.3 Brazil Anti-VEGF Drug Market Size, 2019-2030
6.7.4 Argentina Anti-VEGF Drug Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-VEGF Drug Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Anti-VEGF Drug Sales, 2019-2030
6.8.3 Turkey Anti-VEGF Drug Market Size, 2019-2030
6.8.4 Israel Anti-VEGF Drug Market Size, 2019-2030
6.8.5 Saudi Arabia Anti-VEGF Drug Market Size, 2019-2030
6.8.6 UAE Anti-VEGF Drug Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 F. Hoffmann-La Roche Ltd
7.1.1 F. Hoffmann-La Roche Ltd Company Summary
7.1.2 F. Hoffmann-La Roche Ltd Business Overview
7.1.3 F. Hoffmann-La Roche Ltd Anti-VEGF Drug Major Product Offerings
7.1.4 F. Hoffmann-La Roche Ltd Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.1.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.2 Amgen Inc
7.2.1 Amgen Inc Company Summary
7.2.2 Amgen Inc Business Overview
7.2.3 Amgen Inc Anti-VEGF Drug Major Product Offerings
7.2.4 Amgen Inc Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.2.5 Amgen Inc Key News & Latest Developments
7.3 Pfizer, Inc
7.3.1 Pfizer, Inc Company Summary
7.3.2 Pfizer, Inc Business Overview
7.3.3 Pfizer, Inc Anti-VEGF Drug Major Product Offerings
7.3.4 Pfizer, Inc Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.3.5 Pfizer, Inc Key News & Latest Developments
7.4 Xbrane Biopharma AB
7.4.1 Xbrane Biopharma AB Company Summary
7.4.2 Xbrane Biopharma AB Business Overview
7.4.3 Xbrane Biopharma AB Anti-VEGF Drug Major Product Offerings
7.4.4 Xbrane Biopharma AB Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.4.5 Xbrane Biopharma AB Key News & Latest Developments
7.5 Allergan
7.5.1 Allergan Company Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Anti-VEGF Drug Major Product Offerings
7.5.4 Allergan Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.5.5 Allergan Key News & Latest Developments
7.6 Bayer AG
7.6.1 Bayer AG Company Summary
7.6.2 Bayer AG Business Overview
7.6.3 Bayer AG Anti-VEGF Drug Major Product Offerings
7.6.4 Bayer AG Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.6.5 Bayer AG Key News & Latest Developments
7.7 Regeneron Pharmaceuticals Inc.
7.7.1 Regeneron Pharmaceuticals Inc. Company Summary
7.7.2 Regeneron Pharmaceuticals Inc. Business Overview
7.7.3 Regeneron Pharmaceuticals Inc. Anti-VEGF Drug Major Product Offerings
7.7.4 Regeneron Pharmaceuticals Inc. Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.7.5 Regeneron Pharmaceuticals Inc. Key News & Latest Developments
7.8 Viatris Inc
7.8.1 Viatris Inc Company Summary
7.8.2 Viatris Inc Business Overview
7.8.3 Viatris Inc Anti-VEGF Drug Major Product Offerings
7.8.4 Viatris Inc Anti-VEGF Drug Sales and Revenue in Global (2019-2024)
7.8.5 Viatris Inc Key News & Latest Developments
8 Global Anti-VEGF Drug Production Capacity, Analysis
8.1 Global Anti-VEGF Drug Production Capacity, 2019-2030
8.2 Anti-VEGF Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-VEGF Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-VEGF Drug Supply Chain Analysis
10.1 Anti-VEGF Drug Industry Value Chain
10.2 Anti-VEGF Drug Upstream Market
10.3 Anti-VEGF Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-VEGF Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-VEGF Drug in Global Market
Table 2. Top Anti-VEGF Drug Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Anti-VEGF Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Anti-VEGF Drug Revenue Share by Companies, 2019-2024
Table 5. Global Anti-VEGF Drug Sales by Companies, (K Units), 2019-2024
Table 6. Global Anti-VEGF Drug Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Anti-VEGF Drug Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Anti-VEGF Drug Product Type
Table 9. List of Global Tier 1 Anti-VEGF Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-VEGF Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Anti-VEGF Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Anti-VEGF Drug Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Anti-VEGF Drug Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Anti-VEGF Drug Sales (K Units), 2019-2024
Table 15. By Type - Global Anti-VEGF Drug Sales (K Units), 2025-2030
Table 16. By Application ? Global Anti-VEGF Drug Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Anti-VEGF Drug Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Anti-VEGF Drug Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Anti-VEGF Drug Sales (K Units), 2019-2024
Table 20. By Application - Global Anti-VEGF Drug Sales (K Units), 2025-2030
Table 21. By Region ? Global Anti-VEGF Drug Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Anti-VEGF Drug Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Anti-VEGF Drug Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Anti-VEGF Drug Sales (K Units), 2019-2024
Table 25. By Region - Global Anti-VEGF Drug Sales (K Units), 2025-2030
Table 26. By Country - North America Anti-VEGF Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Anti-VEGF Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Anti-VEGF Drug Sales, (K Units), 2019-2024
Table 29. By Country - North America Anti-VEGF Drug Sales, (K Units), 2025-2030
Table 30. By Country - Europe Anti-VEGF Drug Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Anti-VEGF Drug Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Anti-VEGF Drug Sales, (K Units), 2019-2024
Table 33. By Country - Europe Anti-VEGF Drug Sales, (K Units), 2025-2030
Table 34. By Region - Asia Anti-VEGF Drug Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Anti-VEGF Drug Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Anti-VEGF Drug Sales, (K Units), 2019-2024
Table 37. By Region - Asia Anti-VEGF Drug Sales, (K Units), 2025-2030
Table 38. By Country - South America Anti-VEGF Drug Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Anti-VEGF Drug Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Anti-VEGF Drug Sales, (K Units), 2019-2024
Table 41. By Country - South America Anti-VEGF Drug Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Anti-VEGF Drug Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Anti-VEGF Drug Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Anti-VEGF Drug Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Anti-VEGF Drug Sales, (K Units), 2025-2030
Table 46. F. Hoffmann-La Roche Ltd Company Summary
Table 47. F. Hoffmann-La Roche Ltd Anti-VEGF Drug Product Offerings
Table 48. F. Hoffmann-La Roche Ltd Anti-VEGF Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 50. Amgen Inc Company Summary
Table 51. Amgen Inc Anti-VEGF Drug Product Offerings
Table 52. Amgen Inc Anti-VEGF Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Amgen Inc Key News & Latest Developments
Table 54. Pfizer, Inc Company Summary
Table 55. Pfizer, Inc Anti-VEGF Drug Product Offerings
Table 56. Pfizer, Inc Anti-VEGF Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Pfizer, Inc Key News & Latest Developments
Table 58. Xbrane Biopharma AB Company Summary
Table 59. Xbrane Biopharma AB Anti-VEGF Drug Product Offerings
Table 60. Xbrane Biopharma AB Anti-VEGF Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Xbrane Biopharma AB Key News & Latest Developments
Table 62. Allergan Company Summary
Table 63. Allergan Anti-VEGF Drug Product Offerings
Table 64. Allergan Anti-VEGF Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Allergan Key News & Latest Developments
Table 66. Bayer AG Company Summary
Table 67. Bayer AG Anti-VEGF Drug Product Offerings
Table 68. Bayer AG Anti-VEGF Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Bayer AG Key News & Latest Developments
Table 70. Regeneron Pharmaceuticals Inc. Company Summary
Table 71. Regeneron Pharmaceuticals Inc. Anti-VEGF Drug Product Offerings
Table 72. Regeneron Pharmaceuticals Inc. Anti-VEGF Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Regeneron Pharmaceuticals Inc. Key News & Latest Developments
Table 74. Viatris Inc Company Summary
Table 75. Viatris Inc Anti-VEGF Drug Product Offerings
Table 76. Viatris Inc Anti-VEGF Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Viatris Inc Key News & Latest Developments
Table 78. Anti-VEGF Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 79. Global Anti-VEGF Drug Capacity Market Share of Key Manufacturers, 2022-2024
Table 80. Global Anti-VEGF Drug Production by Region, 2019-2024 (K Units)
Table 81. Global Anti-VEGF Drug Production by Region, 2025-2030 (K Units)
Table 82. Anti-VEGF Drug Market Opportunities & Trends in Global Market
Table 83. Anti-VEGF Drug Market Drivers in Global Market
Table 84. Anti-VEGF Drug Market Restraints in Global Market
Table 85. Anti-VEGF Drug Raw Materials
Table 86. Anti-VEGF Drug Raw Materials Suppliers in Global Market
Table 87. Typical Anti-VEGF Drug Downstream
Table 88. Anti-VEGF Drug Downstream Clients in Global Market
Table 89. Anti-VEGF Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-VEGF Drug Segment by Type in 2023
Figure 2. Anti-VEGF Drug Segment by Application in 2023
Figure 3. Global Anti-VEGF Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Anti-VEGF Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Anti-VEGF Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. Anti-VEGF Drug Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-VEGF Drug Revenue in 2023
Figure 9. By Type - Global Anti-VEGF Drug Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Anti-VEGF Drug Revenue Market Share, 2019-2030
Figure 11. By Type - Global Anti-VEGF Drug Sales Market Share, 2019-2030
Figure 12. By Type - Global Anti-VEGF Drug Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Anti-VEGF Drug Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Anti-VEGF Drug Revenue Market Share, 2019-2030
Figure 15. By Application - Global Anti-VEGF Drug Sales Market Share, 2019-2030
Figure 16. By Application - Global Anti-VEGF Drug Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Anti-VEGF Drug Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Anti-VEGF Drug Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Anti-VEGF Drug Revenue Market Share, 2019-2030
Figure 20. By Region - Global Anti-VEGF Drug Sales Market Share, 2019-2030
Figure 21. By Country - North America Anti-VEGF Drug Revenue Market Share, 2019-2030
Figure 22. By Country - North America Anti-VEGF Drug Sales Market Share, 2019-2030
Figure 23. US Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Anti-VEGF Drug Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Anti-VEGF Drug Sales Market Share, 2019-2030
Figure 28. Germany Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 29. France Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Anti-VEGF Drug Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Anti-VEGF Drug Sales Market Share, 2019-2030
Figure 37. China Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 41. India Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Anti-VEGF Drug Revenue Market Share, 2019-2030
Figure 43. By Country - South America Anti-VEGF Drug Sales Market Share, 2019-2030
Figure 44. Brazil Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Anti-VEGF Drug Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Anti-VEGF Drug Sales Market Share, 2019-2030
Figure 48. Turkey Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Anti-VEGF Drug Revenue, (US$, Mn), 2019-2030
Figure 52. Global Anti-VEGF Drug Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Anti-VEGF Drug by Region, 2023 VS 2030
Figure 54. Anti-VEGF Drug Industry Value Chain
Figure 55. Marketing Channels
